Broadly Neutralizing Synthetic Cannabinoid Vaccines-Reference-Cited by-同舟云学术

Broadly Neutralizing Synthetic Cannabinoid Vaccines

Published:2020-12-15 Issue:1 Volume:1 Page:31-40
ISSN:2691-3704
Container-title:JACS Au
language:en
Short-container-title:JACS Au

Author:

Lin Mingliang¹^ORCID,Lee Jinny Claire¹^ORCID,Blake Steven¹^ORCID,Ellis Beverly¹,Eubanks Lisa M.¹^ORCID,Janda Kim D.¹^ORCID

Affiliation:

1. Department of Chemistry, Department of Immunology and Microbial Science, The Skaggs Institute for Chemical Biology, and The Worm Institute for Research and Medicine (WIRM), The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, United States

Funder

Skaggs Institute for Chemical Biology

Publisher

American Chemical Society (ACS)

Subject

General Medicine

Link

http://pubs.acs.org/doi/pdf/10.1021/jacsau.0c00057

Reference51 articles.

1. Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications

2. Synthetic Cannabinoid–Related Illnesses and Deaths

3. 2018 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 36th Annual Report

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of fentanyl-specific monoclonal antibody (mAb) to antagonize the pharmacological effects of fentanyl;Toxicology and Applied Pharmacology;2024-05

2. Synthesis, structural characterization, analytical profiling, and application to authentic samples of synthesized Phase I metabolites of the synthetic cannabinoid 5F‐MDMB‐PICA;Drug Testing and Analysis;2024-03-15

3. Evaluation of a hapten conjugate vaccine against the “zombie drug” xylazine;Chemical Communications;2024

4. A Review of Immunotherapeutic Approaches for Substance Use Disorders: Current Status and Future Prospects;ImmunoTargets and Therapy;2022-09

5. Development of Cross-Reactive Antibodies for the Identification and Treatment of Synthetic Cannabinoid Receptor Agonist Toxicity;Vaccines;2022-08-04